Décompensation ascitique

Pariente, Alexandre

doi:10.1016/s0399-8320(06)73334-6

Cited by 5 publications

(4 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This finding is similar to that reported by Yao Bataix and Diarra [7] [10]. The oedematous-ascitic syndrome has been described by Pariente [11] as a frequently revealing complication of the disease. The delay in consultation found in almost 50% of cases is probably related to our cultural context where patients first resort to churches and traditional healers in case of illness, before going to the hospital in the absence of improvement.…”

Section: Discussionsupporting

confidence: 91%

“…Ascites was the main complication found during follow-up. This finding is clearly superior to that reported by Pariente [11], which found less than 50% of cases. This frequency could be explained in our patients by the poor therapeutic observance, the absence of therapeutic alternative in case of refractory ascites and especially the high cost of complementary examinations during the follow-up [6].…”

Section: Discussioncontrasting

confidence: 86%

See 1 more Smart Citation

Evolutionary and Pronostic Aspects of Cirrhosis at the University Hospital of Brazzaville (Congo)

Mimiesse¹,

Ngalessami²,

Clausina³

et al. 2020

OJGas

View full text Add to dashboard Cite

Introduction: cirrhosis is a serious pathology that leads to complications whose management remains difficult in our country. This study aimed to evaluate the evolutionary aspects of cirrhosis at the Brazzaville University Hospital. Patients and methods: this was a retrospective study over a period of 18 months (from January 2015 to July 2016), performed in the Gastroenterology Department of the Brazzaville University Hospital. All patients regularly followed for decompensated cirrhosis were included. The studied variables were the epidemiological, clinical and paraclinical characteristics, the occurrence of complications, the survival, and the causes of death. Univariate analysis was used to determine prognostic factors based on the Child Pugh score. Results: There were 43 patients, including 32 men and 11 women, with a mean age of 52 ± 9.5 years. Viral hepatitis B was the most common etiology (39.5%). Child Pugh stage C was found in 60.5%. Oesophageal varices were present in 93% of cases. Survival at 18 months was 72%. In univariate analysis, two variables were significantly associated with decreased survival, including Child Pugh stage C and esophageal varices (grade II and III). Conclusion: cirrhosis remains a worrying pathology because the diagnosis is often made at the stage of often serious complications putting at risk of vital prognosis.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussioncontrasting

confidence: 86%

Evolutionary and Pronostic Aspects of Cirrhosis at the University Hospital of Brazzaville (Congo)

Mimiesse¹,

Ngalessami²,

Clausina³

et al. 2020

OJGas

View full text Add to dashboard Cite

show abstract

“…Ascites and hepatomegaly were the most common clinical signs with 71.55 and 55.1% respectively; Doumbia et al [18] found jaundice (58.1%), hepatomegaly (36.2%) as the main signs. For Pariente [19] ascites is a telltale sign of cirrhosis.…”

Section: Discussionmentioning

confidence: 99%

Effectiveness and Tolerance of Tenofovir Disoproxil Fumarate in Sub-Saharan Viral B Cirrhotic Patients

Samaké¹,

Coulibaly²,

Dicko³

et al. 2019

OJGas

View full text Add to dashboard Cite

Tenofovir reduces viral load during viral cirrhosis B and improves prognosis. The aim of this study was to evaluate the effectiveness and safety of Tenofovir during the treatment of viral B cirrhosis. The study was retrospective and prospective on patients with viral B cirrhosis treated with Tenofovir in the Hepato-Gastroenterology Department of University Hospital Gabriel Touré in Bamako (Mali) and evaluated between three and six months after the start of treatment. We included 89 patients. The mean age was 44.5 ± 16 years with extremes of 18 and 90 years. The sex ratio was 1.2. At inclusion all patients had a detectable viral load with an average of 2651.96 ± 1495.85 IU/ml. Follow-up viral load was undetectable in 84.3% with patients between 3 and 6 months of treatment. The average detectable viral load was only 27.04 ± 21.05 IU/ml. There was also an improvement in hepatocellular function and few side effects. Conclusion: This study shows the interest of Tenofovir in the treatment of viral cirrhosis B with very few adverse effects.

show abstract

“…Une ascite chyleuse spontanée peut survenir dans 1 % des cas de cirrhoses à un stade avancé où elle serait due à une rupture des lymphatiques mésentériques [9]. Cette affection est fréquente dans notre contexte, surtout causée par le virus de l'hépatite B. Cependant, chez notre patiente l'examen physique, la biologie hépatique, l'échographie et l'endoscopie digestive n'ont pas objectivé des signes d'insuffisance hépatocellulaire et d'hypertension portale.…”

Section: Discussionunclassified